THE EFFECT OF INTERLEUKIN-4 (BSF-1) ON INFECTION OF PERIPHERAL-BLOOD MONOCYTE-DERIVED MACROPHAGES WITH HIV-1

被引:41
作者
NOVAK, RM [1 ]
HOLZER, TJ [1 ]
KENNEDY, MM [1 ]
HEYNEN, CA [1 ]
DAWSON, G [1 ]
机构
[1] ABBOTT LABS,N CHICAGO,IL 60064
关键词
D O I
10.1089/aid.1990.6.973
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effects of various cytokines were examined in an in vitro model of human immunodeficiency virus type 1 (HIV-1) infection of human peripheral blood monocyte-derived macrophages (MDM). Monocytes were obtained from blood of normal donors by Ficoll/hypaque gradient centrifugation and adherence. These cells were allowed to mature in the presence of varying concentrations of cytokines. After five days in culture, cells were harvested, counted, and inoculated with S5G7, an HTLV-IIIB subclone. The cells were replated in the presence of the same concentrations of cytokines. Culture supernatants were sampled over 28 days for p24 antigen (Ag) as measured by Ag capture assay. In repeat experiments, the following observations were made: 1. MDM from some donors could be infected only in the presence of tumor necrosis factor-alpha (TNF-α), granulocyte/macrophage colony-stimulating factor (GM-CSF) or interleukin 4 (IL-4); 2. The effect of GM-CSF was variable; TNFα also enhanced HIV replication above controls; 3. IL-4 was the most potent enhancer of HIV-1 replication in MDM of the cytokines tested, inducing p24 Ag levels 75-230 times those seen in control cultures run simultaneously. This effect was dose dependent. Ag production was not observed until Day 14 postinfection in most experiments. Multinucleated giant cell formation was observed only in the presence of IL-4. © 1990, Mary Ann Liebert, Inc. All rights reserved.
引用
收藏
页码:973 / 976
页数:4
相关论文
共 30 条
[1]   DEFECTIVE RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
BENDER, BS ;
FRANK, MM ;
LAWLEY, TJ ;
SMITH, WJ ;
BRICKMAN, CM ;
QUINN, TC .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (02) :409-412
[2]  
BENDER BS, 1986, CLIN EXP IMMUNOL, V84, P166
[3]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[4]  
BRAUN DP, 1988, J CLIN IMMUNOL, V8, P1
[5]  
CRAWFORD RM, 1987, J IMMUNOL, V139, P135
[6]  
CROWE S, 1988, INTERSCIENCE C ANTIM
[7]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[8]  
DEWAURAT S, 1987, J VIROL, V61, P3774
[9]  
DOUGLAS SD, 1981, METHODS STUDYING MON, P33
[10]   THE ACQUIRED IMMUNODEFICIENCY SYNDROME - AN UPDATE [J].
FAUCI, AS ;
MASUR, H ;
GELMANN, EP ;
MARKHAM, PD ;
HAHN, BH ;
LANE, HC .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (06) :800-813